MAPT and Alzheimer disease: Enhanced proteasome activity protects APP-overexpressing mouse and fly models from AD-like pathology9, and conversely, elevated USP11-driven deubiquitination of tau increases pathological tau aggregation51; both imply that ubiquitination can mitigate AD pathology.